118th Congress · SENATE BILLBILL

S. 2044 — End Price Gouging for Medications Act

“A bill to require the Secretary of Health and Human Services to establish reference prices for prescription drugs for purposes of Federal health programs, and for other purposes.”

Health

Introduced Jun 20, 2023

Last action Jun 20, 2023

Pipeline · Bill → Law

Step 1

Introduced

Jun 20, 2023

Step 2

Referred

Jun 20, 2023

HELP

Step 3

Committee

Step 4

Senate

Step 5

House floor

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including the lowest retail price for a drug among specified reference countries. Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.

Provisions · 2 sectionsIntroduced in Senate

Timeline · 2 actions

Jun 20, 2023

Introduced in Senate

Jun 20, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.